Ken Lin, MD
Gynecologic Oncology · Bronx, NYNPI 1063683936
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (54.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AstraZeneca accounts for 61.7% of it on its own, with 7 other manufacturers making up the rest.
Across 19 payments — averaging $134.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Intuitive Surgical$641
- Genentech USA, Inc.$102
- GSK$92
- Tesaro, Inc.$61
- Baxter Healthcare$30
- plus $55 from 2 others
What the payments were for
- Grants$1,39754%
- Travel & lodging$49219%
- Food & beverage$61424%
- Education$612%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $1,583 |
| Intuitive Surgical | 5 | $641 |
| Genentech USA, Inc. | 1 | $102 |
| GSK | 3 | $92 |
| Tesaro, Inc. | 1 | $61 |
| Baxter Healthcare | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Coopersurgical, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$473
- Avastin$102
How this compares
$2,565 in reported general payments places this provider in the 70th percentile of 154 gynecologic oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Imiquimod | 37 | $1,603 |
| Clobetasol Propionate | 25 | $1,135 |
| Letrozole | 18 | $199 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 12 | $32 |
| Oxycodone Hcl | 11 | $26 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Bronx
- June HouBronx$23K
- Ioannis AlagkiozidisBronx$3K
- Gary GoldbergBronx$3K
- Matthew CowanBronx$2K
- Heidi GodoyAlbany$1.1M
- Bhavana PothuriNew York$366K
- Joyce BarlinAlbany$208K
- Wiley BunnSyracuse$201K
- Ghadir SalameBrooklyn$179K
- Richard MooreRochester$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.